Prevalence of substance and hazardous alcohol use and their association with risky sexual behaviour among youth: findings from a population-based survey in Zimbabwe.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
16 Jun 2024
Historique:
medline: 18 6 2024
pubmed: 18 6 2024
entrez: 17 6 2024
Statut: epublish

Résumé

Hazardous drinking (HD) and substance use (SU) can lead to disinhibited behaviour and are both growing public health problems among Southern African youths. We investigated the prevalence of SU and HD and their association with risky sexual behaviour among youth in Zimbabwe. Data analysis from a population-based survey conducted between October 2021 and June 2022 to ascertain the outcomes of a cluster randomised trial (CHIEDZA: Trial registration number:NCT03719521). Trial Stage: Post-results. 24 communities in three provinces in Zimbabwe. Youth aged 18-24 years living in randomly selected households. HD was defined as an Alcohol Use Disorders Identification Test score ≥8, SU was defined as ever use of ≥1 commonly used substances in the local setting. Of 17 585 participants eligible for this analysis, 61% were women and the median age was 20 (IQR: 19-22) years. Overall, 4.5% and 7.0% of participants reported HD and SU, respectively. Men had a substantially higher prevalence than women of HD (8.2% vs 1.9%) and SU (15.1% vs 1.5%). Among men, after adjusting for socio-demographic factors, we found increased odds of having >1 sexual partner in those who engaged in SU (adjusted OR (aOR)=2.67, 95% CI: 2.21 to 3.22), HD (aOR=3.40, 95% CI: 2.71 to 4.26) and concurrent HD and SU (aOR=4.57,95% CI: 3.59 to 5.81) compared with those who did not engage in HD or SU. Similarly, there were increased odds of receiving/providing transactional sex among men who engaged in SU (aOR=2.51, 95% CI: 1.68 to 3.74), HD (aOR=3.60, 95% CI: 2.24 to 5.79), and concurrent HD and SU (aOR=7.74, 95% CI: 5.44 to 11.0). SU was associated with 22% increased odds of inconsistent condom use in men (aOR=1.22, 95% CI: 1.03 to 1.47). In women, the odds of having >1 sexual partner and having transactional sex were also increased among those who engaged in SU and HD. SU and HD are associated with sexual behaviours that increase the risk of HIV acquisition in youth. Sexual and reproductive health interventions must consider HD and SU as potential drivers of risky sexual behaviour in youths.

Identifiants

pubmed: 38885985
pii: bmjopen-2023-080993
doi: 10.1136/bmjopen-2023-080993
doi:

Banques de données

ClinicalTrials.gov
['NCT03719521']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e080993

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Drug Alcohol Depend. 2012 Mar 1;121(3):231-9
pubmed: 21955362
Arch Pediatr Adolesc Med. 2002 Nov;156(11):1101-7
pubmed: 12413337
BMC Public Health. 2023 May 2;23(1):801
pubmed: 37131127
Am Psychol. 1990 Aug;45(8):921-33
pubmed: 2221564
BMC Public Health. 2012 Jul 29;12(1):571
pubmed: 22839700
Lancet Psychiatry. 2016 Mar;3(3):251-64
pubmed: 26905480
Child Youth Serv Rev. 2015 May;52:74-88
pubmed: 25825550
Subst Abuse. 2022 May 20;16:11782218221101011
pubmed: 35645567
BMC Public Health. 2021 Jun 12;21(1):1126
pubmed: 34118914
Addiction. 2022 Apr;117(4):1177-1178
pubmed: 34729833
PLoS One. 2015 Dec 18;10(12):e0145326
pubmed: 26683812
Vulnerable Child Youth Stud. 2017 Oct 2;12(4):360-374
pubmed: 29170681
PLoS One. 2023 Mar 9;18(3):e0272240
pubmed: 36893211
AIDS Behav. 2016 Jan;20 Suppl 1:S19-39
pubmed: 26080689
Trop Med Int Health. 2021 Dec;26(12):1528-1538
pubmed: 34637175
Int J Environ Res Public Health. 2017 Mar 27;14(4):
pubmed: 28346373
Addiction. 2023 Jul;118(7):1201-1215
pubmed: 36807954
AIDS Behav. 2021 Jun;25(6):1777-1789
pubmed: 33219492
Wellcome Open Res. 2023 Nov 7;7:54
pubmed: 38162283
J Subst Use. 2011 Feb;16(1):57-67
pubmed: 21603063
BMC Public Health. 2023 Apr 20;23(1):723
pubmed: 37081488
Syst Rev. 2021 Apr 27;10(1):125
pubmed: 33906677
Lancet Psychiatry. 2018 Dec;5(12):987-1012
pubmed: 30392731
Prev Sci. 2007 Jun;8(2):141-51
pubmed: 17265194
Int J Public Health. 2023 Apr 19;68:1605669
pubmed: 37153699
Subst Abuse Treat Prev Policy. 2024 Jan 11;19(1):6
pubmed: 38212834
Trop Med Int Health. 2014 Apr;19(4):476-88
pubmed: 24479379
Subst Abuse Treat Prev Policy. 2014 Nov 27;9:45
pubmed: 25428774
Afr J Prim Health Care Fam Med. 2021 Mar 23;13(1):e1-e8
pubmed: 33764134

Auteurs

Kudzai Hlahla (K)

Biomedical Research and Training Institute, Harare, Zimbabwe.
University of Zimbabwe Faculty of Medicine and Health Sciences, Harare, Zimbabwe.

Steven Chifundo Azizi (SC)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Victoria Simms (V)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Chido Dziva Chikwari (C)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Ethel Dauya (E)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Tsitsi Bandason (T)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Mandikudza Tembo (M)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Constancia Mavodza (C)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Department of Public Health, Environments and Society, London School of Hygiene & Tropical Medicine, London, UK.

Katharina Kranzer (K)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK.

Rashida Ferrand (R)

Biomedical Research and Training Institute, Harare, Zimbabwe rashida.ferrand@lshtm.ac.uk.
Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH